Dashboard
Manage Tickers

BCDA BioCardia, Inc.

Nasdaq biocardia.com


$ 1.42 $ 0.00 (0 %)    

Friday, 17-Oct-2025 19:58:38 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 604.92 $ 3.94 (0.66 %)
DIA $ 461.73 $ 2.22 (0.48 %)
SPY $ 665.28 $ 3.75 (0.57 %)
TLT $ 91.09 $ -0.14 (-0.15 %)
GLD $ 391.28 $ -7.46 (-1.88 %)
$ 1.45
$ 1.43
$ 1.38 x 9
$ 1.55 x 551
$ 1.40 - $ 1.46
$ 1.00 - $ 3.20
83,444
na
8.41M
$ 1.14
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-11-2025 06-30-2025 10-Q
2 05-14-2025 03-31-2025 10-Q
3 03-26-2025 12-31-2024 10-K
4 11-13-2024 09-30-2024 10-Q
5 08-13-2024 06-30-2024 10-Q
6 05-14-2024 03-31-2024 10-Q
7 03-27-2024 12-31-2023 10-K
8 11-08-2023 09-30-2023 10-Q
9 08-09-2023 06-30-2023 10-Q
10 05-10-2023 03-31-2023 10-Q
11 03-29-2023 12-31-2022 10-K
12 11-09-2022 09-30-2022 10-Q
13 08-10-2022 06-30-2022 10-Q
14 05-11-2022 03-31-2022 10-Q
15 03-29-2022 12-31-2021 10-K
16 11-10-2021 09-30-2021 10-Q
17 08-12-2021 06-30-2021 10-Q
18 05-13-2021 03-31-2021 10-Q
19 03-30-2021 12-31-2020 10-K
20 11-10-2020 09-30-2020 10-Q
21 08-13-2020 06-30-2020 10-Q
22 05-15-2020 03-31-2020 10-Q
23 04-09-2020 12-31-2019 10-K
24 11-19-2019 09-30-2019 10-Q
25 08-14-2019 06-30-2019 10-Q
26 05-15-2019 03-31-2019 10-Q
27 04-02-2019 12-31-2018 10-K
28 11-08-2018 09-30-2018 10-Q
29 08-09-2018 06-30-2018 10-Q
30 05-10-2018 03-31-2018 10-Q
31 03-16-2018 12-31-2017 10-K
32 11-09-2017 09-30-2017 10-Q
33 08-14-2017 06-30-2017 10-Q
34 05-11-2017 03-31-2017 10-Q
35 03-30-2017 12-31-2016 10-K
36 10-17-2016 09-30-2016 10-Q
37 08-02-2016 06-30-2016 10-Q
38 05-03-2016 03-31-2016 10-Q
39 03-25-2016 12-31-2015 10-K
40 10-29-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

biocardia-regains-compliance-with-nasdaq-listing-requirements
BioCardia Regains Compliance With Nasdaq L...
10/02/2025 12:04:10

BioCardia, Inc. (NASDAQ:BCDA), a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pu...

hc-wainwright--co-reiterates-buy-on-biocardia-maintains-25-price-target
HC Wainwright & Co. Reiterates Buy on BioC...
09/22/2025 16:19:33

HC Wainwright & Co. analyst Joseph Pantginis reiterates BioCardia (NASDAQ:BCDA) with a Buy and maintains $25 price target.

biocardia-held-preliminary-clinical-consultation-with-japans-pharmaceutical-and-medical-device-agency-on-its-cardiamp-heart-failure-trial-results
BioCardia Held Preliminary Clinical Consul...
09/22/2025 12:14:28

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
09/18/2025 17:06:02

gold-falls-over-1-darden-posts-downbeat-earnings
Gold Falls Over 1%; Darden Posts Downbeat ...
09/18/2025 16:27:56

nasdaq-surges-100-points-bionano-genomics-shares-plunge
Nasdaq Surges 100 Points; Bionano Genomics...
09/18/2025 13:59:31

biocardia-prices-public-offering-of-48m-shares-and-warrants-at-a-combined-price-of-125-for-up-to-12m-in-gross-proceeds
BioCardia Prices Public Offering Of 4.8M S...
09/18/2025 13:21:18

BioCardia®, Inc. (NASDAQ:BCDA) ("BioCardia" or the "Company"), a developer of cellular and cell-derived therape...

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
09/18/2025 12:09:24

biocardia-announces-primary-endpoint-results-of-open-label-roll-in-cohort-of-cardiamp-cell-therapy-in-chronic-myocardial-ischemia-trial
BioCardia Announces Primary Endpoint Resul...
09/18/2025 11:02:52

BioCardia, Inc. (NASDAQ:BCDA), a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pu...

biocardia-inc-files-for-offering-of-up-to-28m-shares-of-common-stock-together-with-up-to-28m-common-warrants
Biocardia Inc Files For Offering Of Up To ...
09/16/2025 13:49:53

- SEC Filing

biocardia-and-cart-tech-announce-exclusive-partnership-for-development-and-commercialization-of-heart3d-system-for-fusion-imaging
BioCardia And CART-Tech Announce Exclusive...
08/13/2025 12:06:53

biocardia-q2-eps-040-beats-050-estimate
BioCardia Q2 EPS $(0.40) Beats $(0.50) Est...
08/11/2025 13:17:58

BioCardia (NASDAQ:BCDA) reported quarterly losses of $(0.40) per share which beat the analyst consensus estimate of $(0.50) by ...

Core News & Articles
Earnings Scheduled For August 11, 2025
08/11/2025 08:32:28

biocardia-provides-expected-timing-for-regulatory-activities-for-fda-and-japan-pmda-approvals-of-its-cardiamp-cell-therapy-system-and-helix-transendocardial-delivery-catheter
Biocardia Provides Expected Timing For Reg...
08/04/2025 10:02:37

Q3 2025 Helix application for approval to FDAThe Company intends to submit for approval of the Helix Transendocardial Delivery ...

biocardia-submits-cardiamp-autologous-cell-therapy-investigational-heart-failure-treatment-for-clinical-consultation-with-japans-pharmaceuticals-and-medical-devices-agency
BioCardia Submits CardiAMP Autologous Cell...
07/24/2025 13:08:47

BioCardia®, Inc. (NASDAQ:BCDA), a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular a...

henry-ford-health-enrolls-patients-for-biocardias-cardiamp-hf-ii-pivotal-study-for-ischemic-heart-failure-of-reduced-ejection-fraction
Henry Ford Health Enrolls Patients For Bio...
07/16/2025 12:47:24

biocardia-granted-us-patent-titled-radial-and-trans-endocardial-delivery-catheter
BioCardia Granted US Patent Titled 'Radial...
06/25/2025 12:04:31

biocardia-q1-eps-059-misses-039-estimate
BioCardia Q1 EPS $(0.59) Misses $(0.39) Es...
05/14/2025 20:20:53

BioCardia (NASDAQ:BCDA) reported quarterly losses of $(0.59) per share which missed the analyst consensus estimate of $(0.39) b...

Core News & Articles
Earnings Scheduled For May 14, 2025
05/14/2025 08:32:23

biocardia-initiates-patient-enrollment-at-university-of-wisconsin-at-madison-for-ongoing-cardiamp-hf-ii-pivotal-study
BioCardia Initiates Patient Enrollment At ...
05/06/2025 12:02:29

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION